BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33306102)

  • 21. Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership.
    Lynch C; Harrison S; Emery JD; Clelland C; Dorman L; Collins C; Johansen ML; Lawrenson R; Surgey A; Weller D; Jarbøl DE; Balasubramaniam K; Nicholson BD
    Br J Gen Pract; 2023 Feb; 73(727):e88-e94. PubMed ID: 36127155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation.
    Weller D; Vedsted P; Anandan C; Zalounina A; Fourkala EO; Desai R; Liston W; Jensen H; Barisic A; Gavin A; Grunfeld E; Lambe M; Law RJ; Malmberg M; Neal RD; Kalsi J; Turner D; White V; Bomb M; Menon U;
    BMJ Open; 2016 Jul; 6(7):e009641. PubMed ID: 27456325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
    Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Best practices: consensus on performing positron emission tomography-computed tomography for radiation therapy planning and for therapy response assessment.
    Blodgett T
    Semin Ultrasound CT MR; 2010 Dec; 31(6):506-15. PubMed ID: 21147378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.
    Douglas AP; Thursky KA; Worth LJ; Harrison SJ; Hicks RJ; Slavin MA
    Intern Med J; 2019 May; 49(5):615-621. PubMed ID: 30230669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study.
    Moore SP; Antoni S; Colquhoun A; Healy B; Ellison-Loschmann L; Potter JD; Garvey G; Bray F
    Lancet Oncol; 2015 Nov; 16(15):1483-1492. PubMed ID: 26476758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care.
    Norell CH; Butler J; Farrell R; Altman A; Bentley J; Cabasag CJ; Cohen PA; Fegan S; Fung-Kee-Fung M; Gourley C; Hacker NF; Hanna L; Høgdall CK; Kristensen G; Kwon J; McNally O; Nelson G; Nordin A; O'Donnell D; Schnack T; Sykes PH; Zotow E; Harrison S
    Int J Gynecol Cancer; 2020 Nov; 30(11):1748-1756. PubMed ID: 32784203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
    Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I
    Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
    Eden M; Harrison S; Griffin M; Lambe M; Pettersson D; Gavin A; Brewster DH; Lin Y; Johannesen TB; Milne RL; Farrugia H; Nishri D; King MJ; Huws DW; Warlow J; Turner D; Earle CC; Peake M; Rashbass J
    Cancer Epidemiol; 2019 Feb; 58():184-192. PubMed ID: 30639877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions.
    Rose PW; Hamilton W; Aldersey K; Barisic A; Dawes M; Foot C; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Thulesius H; Vedsted P; Young J; Rubin G;
    BMC Fam Pract; 2014 Jun; 15():122. PubMed ID: 24938306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
    Araghi M; Fidler-Benaoudia M; Arnold M; Rutherford M; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Gavin A; Kozie S; Little A; Møller B; St Jacques N; Tervonen H; Walsh P; Woods R; O'Connell DL; Baldwin D; Elwood M; Siesling S; Bray F; Soerjomataram I; ; ; ; ;
    Thorax; 2022 Apr; 77(4):378-390. PubMed ID: 34282033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
    Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
    Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in colorectal cancer incidence in seven high-income countries: a population-based study.
    Araghi M; Soerjomataram I; Bardot A; Ferlay J; Cabasag CJ; Morrison DS; De P; Tervonen H; Walsh PM; Bucher O; Engholm G; Jackson C; McClure C; Woods RR; Saint-Jacques N; Morgan E; Ransom D; Thursfield V; Møller B; Leonfellner S; Guren MG; Bray F; Arnold M
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):511-518. PubMed ID: 31105047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The level of provision of specialist palliative care services in Scotland: an international benchmarking study.
    Inbadas H; Carrasco JM; Gillies M; Clark D
    BMJ Support Palliat Care; 2018 Mar; 8(1):87-92. PubMed ID: 28765106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.